Initial Treatment Approach for GERD vs. Peptic Ulcers

Diagnostic Approach

For patients with typical GERD symptoms, a 4-8 week trial of single-dose PPI therapy is recommended as initial management, according to the American Gastroenterological Association 2, 3
Alarm symptoms, such as dysphagia, weight loss, anemia, or gastrointestinal bleeding, warranting immediate endoscopy, are recommended by the American Gastroenterological Association 2
Lifestyle modifications, including weight management, dietary changes, and avoiding trigger foods, should be recommended concurrently, as suggested by the American Gastroenterological Association 4

The American Gastroenterological Association recommends initial therapy with single-dose PPI for 4-8 weeks, with the option to increase to twice-daily dosing or switch to a more potent PPI if inadequate response, with a strength of evidence based on high-quality trials 1, 3
Response assessment after 4-8 weeks of PPI therapy is crucial, with options to taper to lowest effective dose or consider on-demand therapy with H2RAs/antacids if symptoms resolve, as recommended by the American Gastroenterological Association 4, 5
Long-term management of GERD may involve continuing PPI indefinitely or considering anti-reflux intervention, especially for erosive esophagitis or severe GERD, with a strength of evidence based on high-quality trials 2, 4

The testing approach for GERD involves an empiric PPI trial as appropriate initial management, with endoscopy reserved for treatment failures or alarm symptoms, as recommended by the American Gastroenterological Association 1, 2, 3
Adjunctive therapy for GERD includes lifestyle modifications, such as weight loss and avoiding trigger foods, which play an important supportive role, as suggested by the American Gastroenterological Association 4

Inadequate PPI dosing or duration is a common cause of treatment failure in GERD, with a strength of evidence based on high-quality trials 3
Long-term PPI use for GERD should be at the lowest effective dose to minimize potential side effects, as recommended by the American Gastroenterological Association 4
Patients with atypical or extra-esophageal GERD symptoms may require more aggressive initial therapy and earlier diagnostic testing, with a strength of evidence based on high-quality trials 5